Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Medtronic
McKinsey
Cerilliant
Healthtrust
US Army
Moodys
Chinese Patent Office
Novartis
Argus Health

Generated: January 19, 2018

DrugPatentWatch Database Preview

KEFZOL Drug Profile

« Back to Dashboard

Which patents cover Kefzol, and when can generic versions of Kefzol launch?

Kefzol is a drug marketed by Acs Dobfar and Lilly and is included in two NDAs.

The generic ingredient in KEFZOL is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
Drug patent expirations by year for KEFZOL
Medical Subject Heading (MeSH) Categories for KEFZOL

US Patents and Regulatory Information for KEFZOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acs Dobfar KEFZOL cefazolin sodium INJECTABLE;INJECTION 061773-003 Approved Prior to Jan 1, 1982 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly KEFZOL cefazolin sodium INJECTABLE;INJECTION 062557-001 Sep 10, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Acs Dobfar KEFZOL cefazolin sodium INJECTABLE;INJECTION 061773-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Acs Dobfar KEFZOL cefazolin sodium INJECTABLE;INJECTION 061773-004 Approved Prior to Jan 1, 1982 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Acs Dobfar KEFZOL cefazolin sodium INJECTABLE;INJECTION 061773-005 Sep 8, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly KEFZOL cefazolin sodium INJECTABLE;INJECTION 062557-002 Sep 10, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Acs Dobfar KEFZOL cefazolin sodium INJECTABLE;INJECTION 061773-002 Approved Prior to Jan 1, 1982 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Mallinckrodt
Boehringer Ingelheim
Novartis
Fuji
Cerilliant
Chinese Patent Office
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot